Rol of Pituitary Tumour-Transforming Gene (PTTG) in the pituitary adenomas;Papel de pituitary tumour-transforming gene (PTTG) en los adenomas hipofisarios

Endocrinologia y Nutricion

Volumn 57, Issue 1, 2010, Pages 28-34

  Sánchez Ortiga, Ruth ^a   Tejada, Laura Sánchez ^a   Cabrera, Gloria Peiró ^a   Moreno Pérez, Oscar ^a   Mendoza, Nieves Arias ^b   Ignacio Aranda Lopez F ^a   Alfonso, Antonio Picó ^a  

^a HOSPITAL GENERAL UNIVERSITARIO DE ALICANTE   (Spain)

^b Hospital de Elda   (Spain)

Author keywords

Outcome; Pituitary adenoma; Pituitary tumour; PTTG

Indexed keywords

DOPAMINE RECEPTOR STIMULATING AGENT;

ANEUPLOIDY; APOPTOSIS; CELL INVASION; CELL PROLIFERATION; CLINICAL FEATURE; GENE EXPRESSION REGULATION; GENETIC TRANSCRIPTION; HUMAN; HYPOPHYSIS ADENOMA; PATHOGENESIS; PITUITARY TUMOR TRANSFORMING GENE; PROGNOSIS; REVIEW; TRANSACTIVATION; TUMOR GENE; TUMOR VASCULARIZATION;

HUMANS; NEOPLASM PROTEINS; PITUITARY NEOPLASMS;

EID: 76749145001     PISSN: 15750922     EISSN: 15792021     Source Type: Journal    
DOI: 10.1016/S1575-0922(10)70006-1     Document Type: Review

References (53)

1. Niveiro de Jaime M., Aranda F.I., and Peiro Cabrera G. Patología de los adenomas hipofisarios. Rev Esp Patol 36 (2003) 357-372
2. Pei L., and Melmed S. Isolation and characterization of a pituitary tumor-transforming gen (PTTG). Mol Endocrinol 11 (1997) 433-441
3. Karkar S.S. Molecular cloning, genomic organization, and identification of the promoter for the human pituitary tumor transforming gene (PTTG). Gene 29 (1999) 387-395
4. Zhang X., Horwitz G.A., Prezant T.R., Valentini A., Nakashima M., Bronstein M.D., et al. Structure, expression, and function of human pituitary tumor-transforming gene (PTTG). Mol Endocrinol 13 (1999) 156-166
5. Prezant T.R., Kadioglu P., and Melmed S. An intronless homolog of human proto-oncogen hPTTG is expressed in human pituitary tumors: evidence for hPTTG family. J Clin Endocrinol Metab 84 (1999) 1149-1152
6. Chen L., Puri R., Lefkowit R., and Kakar S.S. Identification of the human pituitary tumor transforming gene (hPTTG) family: molecular estructure, expresion, and chromosomal localization. Gene 248 (2000) 41-50
7. Salehi F., Kovacs K., Scheithauer B.W., Lloyd R.V., and Cusimano M. Pituitary tumor-transforming gene in endocrine and other neoplasms: a review and update. Endocr Relat Cancer 15 (2008) 721-743
8. Assou S., Anahory T., Pantesco V., Le Carrour T., Pellestor F., Klein B., et al. The human cumulus-oocyte complex gene-expression profile. Human Reprod 21 (2006) 1705-1719
9. Chien W., and Pei L. A novel binding factor facilitates nuclear translocation and transcriptional activation function of the pituitary tumor-transforming gene product. J Biol Chem 275 (2000) 19422-19427
10. Tong Y., Tan Y., Zhou C., and Melmed S. Pituitary tumor transforming gene interacts with Sp1 to modulate G1/S cell phase transition. Oncogene 26 (2007) 5596-5605
11. Zapata A.G. La regulación del ciclo celular: modelos experimentales sencillos que resultan en premios Nobel. Anal Real Acad Farm 67 (2001) 1-14
12. Tanaka T., Fuchs J., Loidl J., and Nasmyth K. Cohesin ensures bipolar attachment of microtubules to sister centromeres and resists their precocious separation. Nat Cell Biol 2 (2000) 492-499
13. Zou H., McGarry T.J., Bernal T., and Kirschner M.W. Identification of a vertebrate sister-chromatid separation inhibitor involved in transformation and tumorigenesis. Science 285 (1999) 418-422
14. Tong Y., and Eigler T. Transcriptional targets for pituitary tumortransforming gene-1. J Mol Endocrinol 43 (2009) 179-185
15. Boelaert K., Yu R., Tannahill L.A., Stratford A.L., Khanim F.L., Eggo M.C., et al. PTTG's C-terminal PXXP motifs modulate critical cellular processes in vitro. J Mol Endocrinol 33 (2004) 663-677
16. Romero F., Multom M.C., Ramos-Morales F., Dominguez A., Bernal J.A., Pintor-Toro J.A., et al. Human securin, hPTTG, is associated with Ku heterodimer, the regulatory subunit of the DNA-dependent protein kinase. Nucleic Acids Res 29 (2001) 1300-1307
17. Yu R., Heany A.P., Lu W., Chen J., and Melmed S. Pituitary tumor transforming gene causes aneuploidy and p53-dependent and p53- independent apoptosis. J Biol Chem 275 (2000) 36502-36505
18. Hamid T., and Kakar S.S. PTTG/securin activates expression of p53 and modulates its function. Mol Cancer 3 (2004) 18
19. Chesnokova V., and Melmed S. Pituitary tumour-transforming gene (PTTG) and pituitary senescence. Horm Res 71 Suppl 2 (2009) 82-87
20. Heaney A.P., Horwitz G.A., Wang Z., Singson R., and Melmed S. Early involvement of estrogen-induced pituitary tumor transforming gene and fibroblast growth factor expression in prolactinoma pathogenesis. Nat Med 5 (1999) 1317-1321
21. Heaney A.P., Fernando M., and Melmed S. Functional role of estrogen in pituitary tumor pathogenesis. J Clin Invest 109 (2002) 277-283
22. Yin H., Fujimoto N., Maruyama S., and Asano K. Strain difference in regulation of pituitary tumor transforming gene (PTTG) in estrogen-induced pituitary tumorigenesis in rats. Jpn J Cancer Res 92 (2001) 1034-1040
23. Chamaon K., Kirches E., Kanakis D., Braeuninger S., Dietzmann K., and Mawrin C. Regulation of the pituitary tumor transforming gene by insulin-like-growth factor-I and insulin differs between malignant and nonneoplastic astrocytes. Biochem Biophys Res Commun 331 (2005) 86-92
24. Chamaon K., Kanakis D., Mawrin C., Dietzmann K., and Kirches E. Transcripts of PTTG and growth factors bFGF and IGF-1 are correlated in pituitary adenomas. Exp Clin Endocrinol Diabetes (2009) May 26 [Epub ahead of print]
25. Thompson A.D., and Kakar S.S. Insulin and IGF-1 regulate the expression of the pituitary tumor transforming gene (PTTG) in breast tumor cells. FEBS Letters 579 (2005) 3195-3200
26. Vlotides G., Cruz-Soto M., Rubinek T., Eigler T., Auernhammer C.J., and Melmed S. Mechanisms for growth factor-induced pituitary tumor transforming gene-1 expression in pituitary folliculostellate TtT/GF cells. Mol Endocrinol 20 (2006) 3321-3335
27. Zhou C., Liu S., Zhou X., Xue L., Quan L., Lu N., et al. Overexpression of human pituitary tumor transforming gene (hPTTG), is regulated by beta-catenin/TCF pathway in human esophageal squamous cell carcinoma. Int J Cancer 113 (2005) 891-898
28. Gueorguiev M., and Grossman A.B. Pituitary gland and beta-catenin signaling: from ontogeny to oncogenesis. Pituitary 12 (2009) 245-255
29. Tfelt-Hansen J., Kanuparthi D., and Chattopadhyay N. The emerging role of pituitary tumor transforming gene in tumorigenesis. Clin Med Res 4 (2006) 130-137
30. Stoika R., and Melmed S. Expression and function of pituitary tumour transforming gene for T-lymphocyte activation. Br J Haematol 119 (2002) 1070-1074
31. Akino K., Akita S., Mizuguchi T., Takumi I., Yu R., Wang X.Y., et al. A novel molecular marker of pituitary tumor transforming gene involves in a rat liver regeneration. J Surg Res 129 (2005) 142-146
32. Pei L. Activation of mitogen-activated protein kinase cascade regulates pituitary tumor-transforming gene transactivation function. J Biol Chem 275 (2000) 31191-31198
33. Ramos-Morales F., Dominguez A., Romero F., Luna R., Multon M.C., Pintor-Toro J.A., et al. Cell cycle regulated expression and phosphorylation of hpttg proto-oncogene product. Oncogene 19 (2000) 403-409
34. Wang Z., and Melmed S. Pituitary tumor transforming gene (PTTG) transforming and transactivation activity. J Biol Chem 275 (2000) 7459-7461
35. Vlotides G., Eigler T., and Melmed S. Pituitary tumor-transforming gene: physiology and implications for tumorigenesis. Endocr Rev 28 (2007) 165-186
36. Kim D.S., Fong J., Read M.L., and McCabe C.J. The emerging role of pituitary tumour transforming gene (PTTG) in endocrine tumourigenesis. Mol Cell Endocrinol 15 278 (2007) 1-6
37. Abbud R.A., Takumi I., Barker E.M., Ren S.G., Chen D.Y., Wawrowsky K., et al. Early multipotential pituitary focal hyperplasia in the alpha-subunit of glycoprotein hormone-driven pituitary tumortransforming gene transgenic mice. Mol Endocrinol 19 (2005) 1383-1391
38. Boelaert K., Tannahill L.A., Bulmer J.N., Kachilele S., Chan S.Y., Kim D., et al. A potential role for PTTG/securin in the developing human fetal brain. FASEB J 17 (2003) 1631-1639
39. Pei L. Identification of c-myc as a down-stream target for pituitary tumor-transforming gene. J Biol Chem 276 (2001) 8484-8491
40. Yu R., Lu W., Chen J., McCabe C.J., and Melmed S. Overexpressed pituitary tumor-transforming gene causes aneuploidy in live human cells. Endocrinology 144 (2003) 4991-4998
41. Zhang X., Horwitz G.A., Heaney A.P., Nakashima M., Prezant T.R., Bronstein M.D., et al. Pituitary tumor transforming gene (PTTG) expression in pituitary adenomas. J Clin Endocrinol Metab 84 (1999) 761-767
42. Ishikawa H., Heaney A.P., Yu R., Horwitz G.A., and Melmed S. Human pituitary tumor-transforming gene induces angiogenesis. J Clin Endocrinol Metab 86 (2001) 867-874
43. McCabe C.J., Boelaert K., Tannahill L.A., Heaney A.P., Stratford A.L., Khaira J.S., et al. Vascular endothelial growth factor, its receptor KDR/Flk-1, and pituitary tumor transforming gene in pituitary tumors. J Clin Endocrinol Metab 87 (2002) 4238-4244
44. McCabe C.J., Khaira J.S., Boelaert K., Heaney A.P., Tannahill L.A., Hussain S., et al. Expression of pituitary tumour transforming gene (PTTG) and fibroblast growth factor-2 (FGF-2) in human pituitary adenomas: relationships to clinical tumour behaviour. Clin Endocrinol (Oxf) 58 (2003) 141-150
45. Hunter J.A., Skelly R.H., Aylwin S.J., Geddes J.F., Evanson J., Besser G.M., et al. The relationship between pituitary tumour transforming gene (PTTG) expression and in vitro hormone and vascular endothelial growth factor (VEGF) secretion from human pituitary adenomas. Eur J Endocrinol 148 (2003) 203-211
46. Filippella M., Galland F., Kujas M., Young J., Faggiano A., Lombardi G., et al. Pituitary tumour transforming gene (PTTG) expression correlates with the proliferative activity and recurrence status of pituitary adenomas: a clinical and immunohistochemical study. Clin Endocrinol (Oxf) 65 (2006) 536-543
47. Minematsu T., Suzuki M., Sanno N., Takekoshi S., Teramoto A., and Osamura R.Y. PTTG overexpression is correlated with angiogenesis in human pituitary adenomas. Endocr Pathol 17 (2006) 143-153
48. Cristina C., Díaz-Torga G.S., Goya R.G., Kakar S.S., Perez-Millán M.I., Passos V.Q., et al. PTTG expression in different experimental and human prolactinomas in relation to dopaminergic control of lactotropes. Mol Cancer 6 (2007) 4
49. Wierinckx A., Auger C., Devauchelle P., Reynaud A., Chevallier P., Jan M., et al. A diagnostic marker set for invasion, proliferation, and aggressiveness of prolactin pituitary tumors. Endocr Relat Cancer 14 (2007) 887-900
50. Tena-Suck M.L., Ortiz-Plata A., and De la Vega H.A. Phosphatase and tensin homologue and pituitary tumor-transforming gene in pituitary adenomas. Clinical-pathologic and immunohistochemical analysis. Ann Diagn Pathol 12 (2008) 275-282
51. Chesnokova V., Zonis S., Kovacs K., Ben-Shlomo A., Wawrowsky K., Bannykh S., et al. p21(Cip1) restrains pituitary tumor growth. Proc Natl Acad Sci U S A 105 (2008) 17498-17503
52. Passos V.Q., Fortes M.A., Giannella-Neto D., and Bronstein M.D. Genes differentially expressed in prolactinomas responsive and resistant to dopamine agonists. Neuroendocrinology 89 (2009) 163-170
53. Horwitz G.A., Miklovsky I., Heaney A.P., Ren S.G., and Melmed S. Human pituitary tumor-transforming gene (PTTG1) motif suppresses prolactin expression. Mol Endocrinol 17 (2003) 600-609